A perspective on the EANM procedure guidelines for radionuclide therapy with 177Lu-labelled PSMA-ligands

被引：0
|
作者：
Gericke, Germo [1 ]
机构：
[1] Novartis Co, Adv Accelerator Applicat, CH-1204 Geneva, Switzerland
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2021年 / 48卷 / 09期
关键词：
1;
D O I：
10.1007/s00259-021-05400-5
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：2666 / 2667
页数：2
相关论文
共 50 条
  • [11] Joint EANM/SNMMI procedure guideline for the use of 177Lu-labeled PSMA-targeted radioligand-therapy (177Lu-PSMA-RLT)
    Clemens Kratochwil
    Wolfgang P. Fendler
    Matthias Eiber
    Michael S. Hofman
    Louise Emmett
    Jeremie Calais
    Joseph R. Osborne
    Amir Iravani
    Phillip Koo
    Liza Lindenberg
    Richard P. Baum
    Murat Fani Bozkurt
    Roberto C. Delgado Bolton
    Samer Ezziddin
    Flavio Forrer
    Rodney J. Hicks
    Thomas A. Hope
    Levent Kabasakal
    Mark Konijnenberg
    Klaus Kopka
    Michael Lassmann
    Felix M. Mottaghy
    Wim J. G. Oyen
    Kambiz Rahbar
    Heiko Schoder
    Irene Virgolini
    Lisa Bodei
    Stefano Fanti
    Uwe Haberkorn
    Ken Hermann
    European Journal of Nuclear Medicine and Molecular Imaging, 2023, 50 : 2830 - 2845
  • [12] Joint EANM/SNMMI procedure guideline for the use of 177Lu-labeled PSMA-targeted radioligand-therapy (177Lu-PSMA-RLT)
    Kratochwil, Clemens
    Fendler, Wolfgang P.
    Eiber, Matthias
    Hofman, Michael S.
    Emmett, Louise
    Calais, Jeremie
    Osborne, Joseph R.
    Iravani, Amir
    Koo, Phillip
    Lindenberg, Liza
    Baum, Richard P.
    Bozkurt, Murat Fani
    Bolton, Roberto Delgado C.
    Ezziddin, Samer
    Forrer, Flavio
    Hicks, Rodney J.
    Hope, Thomas A.
    Kabasakal, Levent
    Konijnenberg, Mark
    Kopka, Klaus
    Lassmann, Michael
    Mottaghy, Felix M.
    Oyen, Wim J. G.
    Rahbar, Kambiz
    Schoder, Heiko
    Virgolini, Irene
    Bodei, Lisa
    Fanti, Stefano
    Haberkorn, Uwe
    Hermann, Ken
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (09) : 2830 - 2845
  • [13] Radionuclide therapy with 177Lu PSMA for prostate cancer
    da Rocha, Euclides Timoteo
    BIOPHYSICAL REVIEWS, 2021, 13 (06) : 1527 - 1527
  • [14] Radionuclide Therapy With 177Lu-PSMA in a Patient With Hepatocellular Carcinoma
    Pretet, Valentin
    Giraudet, Anne Laure
    Vergnaud, Laure
    Paquet, Emilie
    Kryza, David
    CLINICAL NUCLEAR MEDICINE, 2024, 49 (06) : 584 - 586
  • [15] EANM-EAU consensus on PSMA PET/CT in respect to radioligand therapy ([177Lu]Lu-PSMA)
    Stefano Fanti
    Jolanta Kunikowska
    Jochen Walz
    Wim Witjes
    Anders Bjartell
    European Journal of Nuclear Medicine and Molecular Imaging, 2022, 49 : 3328 - 3329
  • [16] EANM-EAU consensus on PSMA PET/CT in respect to radioligand therapy ([177Lu]Lu-PSMA)
    Fanti, Stefano
    Kunikowska, Jolanta
    Walz, Jochen
    Witjes, Wim
    Bjartell, Anders
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (10) : 3328 - 3329
  • [17] Peptide receptor radionuclide therapy with 90Y/177Lu-labelled peptides for inoperable head and neck paragangliomas (glomus tumours)
    Ameya D. Puranik
    Harshad R. Kulkarni
    Aviral Singh
    Richard P. Baum
    European Journal of Nuclear Medicine and Molecular Imaging, 2015, 42 : 1223 - 1230
  • [18] Peptide receptor radionuclide therapy with 90Y/177Lu-labelled peptides for inoperable head and neck paragangliomas (glomus tumours)
    Puranik, Ameya D.
    Kulkarni, Harshad R.
    Singh, Aviral
    Baum, Richard P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 (08) : 1223 - 1230
  • [19] [177Lu]PSMA-617 radionuclide therapy shows promise
    Bradley, Conor A.
    NATURE REVIEWS UROLOGY, 2018, 15 (08) : 468 - 468
  • [20] [177Lu]PSMA-617 radionuclide therapy shows promise
    Conor A. Bradley
    Nature Reviews Urology, 2018, 15 : 468 - 468
12345